Nicolas Coudray, Michelle C Juarez, Maressa C Criscito, Adalberto Claudio Quiros, Reason Wilken, Stephanie R Jackson Cullison, Mary L Stevenson, Nicole A Doudican, Ke Yuan, Jamie D Aquino, Daniel M Klufas, Jeffrey P North, Siegrid S Yu, Fadi Murad, Emily Ruiz, Chrysalyne D Schmults, Cristian D Cardona Machado, Javier Cañueto, Anirudh Choudhary, Alysia N Hughes, Alyssa Stockard, Zachary Leibovit-Reiben, Aaron R Mangold, Aristotelis Tsirigos, John A Carucci
{"title":"Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosis.","authors":"Nicolas Coudray, Michelle C Juarez, Maressa C Criscito, Adalberto Claudio Quiros, Reason Wilken, Stephanie R Jackson Cullison, Mary L Stevenson, Nicole A Doudican, Ke Yuan, Jamie D Aquino, Daniel M Klufas, Jeffrey P North, Siegrid S Yu, Fadi Murad, Emily Ruiz, Chrysalyne D Schmults, Cristian D Cardona Machado, Javier Cañueto, Anirudh Choudhary, Alysia N Hughes, Alyssa Stockard, Zachary Leibovit-Reiben, Aaron R Mangold, Aristotelis Tsirigos, John A Carucci","doi":"10.1038/s41746-025-01496-3","DOIUrl":null,"url":null,"abstract":"<p><p>Primary cutaneous squamous cell carcinoma (cSCC) is responsible for ~10,000 deaths annually in the United States. Stratification of risk of poor outcome at initial biopsy would significantly impact clinical decision-making during the initial post operative period where intervention has been shown to be most effective. Using whole-slide images (WSI) from 163 patients from 3 institutions, we developed a self supervised deep-learning model to predict poor outcomes in cSCC patients from histopathological features at initial diagnosis, and validated it using WSI from 563 patients, collected from two other academic institutions. For disease-free survival prediction, the model attained a concordance index of 0.73 in the development cohort and 0.84 in the Mayo cohort. The model's interpretability revealed that features like poor differentiation and deep invasion were strongly associated with poor prognosis. Furthermore, the model is effective in stratifying risk among BWH T2a and AJCC T2, known for outcome heterogeneity.</p>","PeriodicalId":19349,"journal":{"name":"NPJ Digital Medicine","volume":"8 1","pages":"105"},"PeriodicalIF":12.4000,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11830021/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Digital Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41746-025-01496-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Primary cutaneous squamous cell carcinoma (cSCC) is responsible for ~10,000 deaths annually in the United States. Stratification of risk of poor outcome at initial biopsy would significantly impact clinical decision-making during the initial post operative period where intervention has been shown to be most effective. Using whole-slide images (WSI) from 163 patients from 3 institutions, we developed a self supervised deep-learning model to predict poor outcomes in cSCC patients from histopathological features at initial diagnosis, and validated it using WSI from 563 patients, collected from two other academic institutions. For disease-free survival prediction, the model attained a concordance index of 0.73 in the development cohort and 0.84 in the Mayo cohort. The model's interpretability revealed that features like poor differentiation and deep invasion were strongly associated with poor prognosis. Furthermore, the model is effective in stratifying risk among BWH T2a and AJCC T2, known for outcome heterogeneity.
期刊介绍:
npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics.
The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.